Quantcast

Global Synthetic Biology Market 2014-2018

July 28, 2014

DUBLIN, July 28, 2014 /PRNewswire/ – Research and Markets has announced the addition of the “Global Synthetic Biology Market 2014-2018″ report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769



The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment.



The analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018.



The Global Synthetic Biology market can be categorized on the basis of technology into four segments: Genome Engineering. DNA Sequencing, Bioinformatics, and Biological Components and Integrated Systems.



Key Topics Covered:



01. Executive Summary



02. List of Abbreviations



03. Scope of the Report



04. Market Research Methodology



05. Introduction



06. Market Landscape



07. Market Segmentation by Technology



08. Market Segmentation by Product



09. Market Segmentation by Applications



10. Geographical Segmentation



11. Buying Criteria



12. Market Growth Drivers



13. Drivers and their Impact



14. Market Challenges



15. Impact of Drivers and Challenges



16. Market Trends



17. Trends and their Impact



18. Vendor Landscape



19. Key Vendor Analysis



20. Other Reports in this Series



Companies Mentioned:

    --  Amyris Inc.
    --  E. I. du Pont de Nemours and Co.
    --  Thermo Fisher Scientific Inc.
    --  Synthetic Genomics Inc.
    --  Algenol Biofuels Inc.
    --  ATG:biosynthetics GmbH
    --  Bayer AG
    --  Bioneer Corp.
    --  Biosearch Technologies Inc.
    --  Bristol-Myers Squibb Co.
    --  CBC Comprehensive Biomarker Center GmbH
    --  Cobalt Technologies
    --  Evolva Holdings SA
    --  Exxon Mobil Corp.
    --  GeneWorks Pty Ltd.
    --  Genomatica Inc.
    --  Gevo Inc.
    --  Ginkgo Bioworks
    --  Green Biologics Ltd.
    --  New England Biolabs Inc.
    --  OriGene Technologies Inc.
    --  REG Life Sciences LLC
    --  Royal DSM
    --  Synthorx Inc.

For more information visit http://www.researchandmarkets.com/research/dtxhfz/global_synthetic

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets


Source: PR Newswire



comments powered by Disqus